Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.

Employees

397

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

End-of-day quote OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

11/06	Triple update for Biosynex
25/05	Paris climbs on hopes of Middle East de-escalation

Market Cap	16.33M 18.73M 15.12M 14.16M 26.55M 1.77B 26.71M 179M 69.54M 870M 70.31M 68.8M 3.02B	P/E 2024	-0.43x	P/E 2025	-0.19x
Enterprise Value	69.52M 79.73M 64.39M 60.27M 113M 7.52B 114M 764M 296M 3.7B 299M 293M 12.86B	EV / Sales 2024	0.71x	EV / Sales 2025	0.68x
Free-Float	40.35%	Yield 2024 *	-	Yield 2025	-

11/06	Triple update for Biosynex
25/05	Paris climbs on hopes of Middle East de-escalation
25/05	Biosynex announces the divestment of its molecular biology business
25/05	An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
08/05	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
07/05	Biosynex SA Auditor Raises 'Going Concern' Doubt	CI
21/04	Thales, Vivendi, Mercialys, GTT... stocks to watch today in Paris
21/04	Biosynex postpones publication of annual accounts
24/03	Abivax, Ekinops, Sanofi... stocks to watch today in Paris
24/03	Observation period extended for Biosynex
06/02	A Biosynex Subsidiary to Receive $1.8 Million Grant
06/02	Aperam, Société Générale, Stellantis: Key Stocks to Watch Today in Paris
23/01	JCDecaux, Sanofi, Sword Group... Stocks to Watch Today in Paris

24/10/24	BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY	EQ
28/04/23	Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	AQ
13/04/23	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
15/03/23	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
01/02/23	Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement	AQ

Biosynex Stock OTC Markets

Stocks

BSYXF

FR0011005933

Medical Equipment, Supplies & Distribution

Valuation: Biosynex

Latest news : Biosynex

Press Releases: Biosynex

News in other languages: Biosynex

Managers and Directors: Biosynex

Diagnostic & Testing Substances

Financials

Company Profile

Income Statement and Estimates

14/06	Agenda des dividendes et des AG France : GTT, Alten et Exail sur les tablettes
11/06	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
11/06	Une bonne grosse purge avant SpaceX
11/06	Triple actualité pour Biosynex
11/06	BIOSYNEX SA: BIOSYNEX ANNONCE LA REALISATION DEFINITIVE DE LA CESSION DE SON ACTIVITE DE BIOLOGIE MOLECULAIRE

Manager	Title	Age	Since
Larry Abensur CEO	Chief Executive Officer	71	24/06/2015
Thierry Paper CTO	Chief Tech/Sci/R&D Officer	63	01/01/2015
Oren Bitton PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Thierry Paper BRD	Director/Board Member	63	24/06/2015
Thomas Lamy BRD	Director/Board Member	-	24/06/2015
Larry Abensur CHM	Chairman	71	24/06/2015

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOSYNEX	-.--%	-.--%	-	-	18.73M
GUARDANT HEALTH, INC.	-2.20%	+0.12%	+168.17%	+260.45%	17.47B
BIOMÉRIEUX	-2.03%	+0.22%	-44.13%	-24.87%	9.33B
LANTHEUS HOLDINGS, INC.	+0.92%	-0.63%	+31.15%	+12.65%	6.76B
CARIS LIFE SCIENCES, INC.	+0.76%	+2.78%	-32.22%	-	5.22B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.64%	-3.63%	-27.65%	-32.18%	4.88B
ANDON HEALTH CO., LTD.	+10.00%	+20.71%	+105.80%	+106.31%	4.54B
10X GENOMICS, INC.	+3.81%	+20.51%	+221.51%	-37.63%	4.41B
DIASORIN S.P.A.	+0.06%	-3.27%	-30.74%	-32.94%	3.95B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.74%	-2.46%	-17.42%	-42.80%	2.57B
Average	+0.86%	+4.09%	+41.61%	+26.12%	6.57B
Weighted average by Cap.	+0.10%	+3.17%	+62.99%	+80.18%

	2024	2025
Net sales	101M 116M 93.7M 87.71M 164M 10.95B 165M 1.11B 431M 5.39B 436M 426M 18.71B	95.19M 109M 88.16M 82.53M 155M 10.3B 156M 1.05B 405M 5.07B 410M 401M 17.61B
Net income	-43.33M -49.7M -40.13M -37.57M -70.46M -4.69B -70.88M -476M -185M -2.31B -187M -183M -8.01B	-58.22M -66.78M -53.92M -50.48M -94.67M -6.3B -95.25M -640M -248M -3.1B -251M -245M -10.77B
Net Debt	52.94M 60.71M 49.03M 45.9M 86.07M 5.73B 86.6M 582M 225M 2.82B 228M 223M 9.79B	53.19M 61M 49.26M 46.12M 86.49M 5.76B 87.01M 584M 226M 2.83B 229M 224M 9.84B